CRB-317

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameCRB-317
Drug Alias NameCRB-317
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid CB2 receptor agonists
TargetsCannabinoid CB2 receptor
Therapy Area/IndicationsInflammationFibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCorbus Pharmaceuticals Holdings Inc
China Registration ClassN/A

Develop Information

Active CompaniesCorbus Pharmaceuticals Holdings Inc
Inactive CompaniesN/A
Active IndicationsInflammationFibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A